Vol 35, Issue 5

The impetus to consider inflammation as potentially relevant to the pathoetiology of domain-based psychopathology (eg, anhedonia) and/or mental disorders, is provided by a confluence of factors discussed here.

The studies reviewed in this article provide a new model for clinical practice-one where the treatment of depressed patients is not governed by trial and error, but rather where patients can access new interventions sooner.

A drug once seen as a widespread danger to society is now experiencing renewed interest as a treatment for medical conditions, including a number of mental health conditions. This brief review explores 5 key issues clinicians can consider when encountering the therapeutic cannabis user.

To understand the experiences and needs of the aging LGBTQ population, it is important to consider the culture, politics, and social norms that existed when these elders came of age. Clinicians can play a vital role by creating a safe and open environment that allows people to be themselves.

Four psychiatrists have joined the distinguished members of our Editorial Board. And our Editorial Director passes the torch.

Psychogenic purpura is a rare and poorly understood syndrome. However, early recognition and intervention can lead to remissions which may last years.

Why do positive emotional feelings make us feel more connected to others?

The US is facing the largest epidemic of opioid overdose deaths in its history. This CME addresses issues associated with the medication-assisted treatment protocol for opioid use disorder.

It is time for the psychiatric and wider medical world to embrace lessons from the growing science of resilience to treat the wide range of stress-related medical and psychiatric disorders more effectively.

I wanted this to be like a fairy tale walk in the woods before kids, careers, blood clots and bone mets...

Why aren’t we Americans as happy as we should be, given all the wonderful things we have in our lives?

With greater expertise in user experiences, psychiatrists can position themselves to more strongly guide technology companies in building and implementing better apps.

DSM focuses on the difference between Bipolar I and II. But there’s another way to categorize the illness that may have more relevance to treatment.